FLU-ID regimen

chemotherapy protocol consisting of fludarabine and idarubicin; used in treatment of mantle cell lymphomas

Therapeutics: 1190486
- Drug Therapy: 300623
  - Combination Drug Therapy: 12155
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - FLU-ID regimen: 1
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - FLU-ID regimen: 1
- Clinical Protocols
  - Antineoplastic Protocols: 58
    - Antineoplastic Combined Chemotherapy Protocols: 36
      - FLU-ID regimen: 1
Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 664
      - Purine Nucleosides: 362
        Adenosine: 12597
        Vidarabine: 559
        FLU-ID regimen: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6937
  - Purine Nucleosides: 362
    - Adenosine: 12597
      - Vidarabine: 559
        FLU-ID regimen: 1
  - Arabinonucleosides: 1
    - Vidarabine: 559
      - FLU-ID regimen: 1
Organic Chemicals: 140
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Polycyclic Aromatic Hydrocarbons: 2081
        Naphthacenes
        Anthracyclines: 9615
        Daunorubicin: 2659
        Idarubicin: 932
        FLU-ID regimen: 1
Polycyclic Compounds: 7
- Polycyclic Aromatic Hydrocarbons: 2081
  - Naphthacenes
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Idarubicin: 932
        FLU-ID regimen: 1
Carbohydrates: 22516
- Glycosides: 2186
  - Aminoglycosides: 5203
    - Anthracyclines: 9615
      - Daunorubicin: 2659
        Idarubicin: 932
        FLU-ID regimen: 1

F Ronconi Selected Research

F Ronconi Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure